Banque Pictet & Cie’s Structure Therapeutics GPCR Stock Holding History

Banque Pictet & Cie’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33M	Sell	43,332 -6,035	-12%	-$267K	0.01%	186
2026 Q1	$2.38M	Sell	49,367 -10,514	-18%	-$720K	0.02%	200
2025 Q4	$4.16M	Sell	59,881 -4,304	-7%	-$176K	0.02%	163
2025 Q3	$1.8M	Sell	64,185 -6,216	-9%	-$124K	0.01%	230
2025 Q2	$1.46M	Sell	70,401 -11,365	-14%	-$250K	0.01%	227
2025 Q1	$1.42M	Buy	81,766 +7,589	+10%	+$186K	0.01%	228
2024 Q4	$2.01M	Sell	74,177 -6,876	-8%	-$244K	0.01%	211
2024 Q3	$3.56M	Buy	+81,053	New	+$3.13M	0.03%	163

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Banque Pictet & Cie's GPCR Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Structure Therapeutics (GPCR) stake by 12% in Q2 2026, selling an estimated $267K and leaving 43,332 shares worth $2.33M. The position accounts for 0.01% of the portfolio, ranked #186.

Banque Pictet & Cie first reported a position in GPCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.16M in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Banque Pictet & Cie held 43,332 shares of Structure Therapeutics worth $2.33M as of Q2 2026.
Banque Pictet & Cie sold 6,035 Structure Therapeutics shares in Q2 2026, an estimated $267K.
Structure Therapeutics made up 0.01% of Banque Pictet & Cie's portfolio in Q2 2026, its #186 holding.
Banque Pictet & Cie first reported a position in Structure Therapeutics in Q3 2024 and has held it in 8 quarters since.
Banque Pictet & Cie's Structure Therapeutics position peaked at $4.16M in Q4 2025.
191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.